Ferring Pharmaceuticals announced strong performance results for 2024, with one part of the announcement standing out as ...

While supply chain interruptions are a strong possibility, the tariffs also provide the industry with a chance to improve ...

As the tariff situation continues to unfold in unexpected ways, the pharma industry must prepare for multiple eventualities. This includes making plans for the most impactful outcomes, which could ...

A new study shows that varenicline combined with brief remote counseling significantly improves vaping abstinence in in patients between 16 and 25 years of age.

The submission is backed by clinical data from over 2,100 patients, including two pivotal Phase III trials in patients ...

Pooja Lal, VP of strategy and commercial content at Veeva Systems, spoke with Pharmaceutical Executive about some of the ways ...

Chris Springate, CEO, ARC Medical, discusses how postoperative adhesions continue to cause chronic pain, infertility, and life-threatening complications—despite advances in surgical techniques and ...

The level on tariffs on Chinese origin products is astronomical. We also have a 10% tariff on products from Europe, with a carve out for very specific pharmaceutical products. How long that will last ...

Results from the dual Phase III TRIUMpH trials demonstrated the statistical superiority of tegoprazan over lansoprazole in ...

CMS’ draft guidance on real-world data study protocols marks a significant move toward transparency and rigor in Medicare ...

In the Phase III ARISE trial, Cobenfy administered as an adjunctive treatment to atypical antipsychotics for patients with ...

What effect will the tariffs have on drug pricing and patient access? Arda Ural: Over the last 20 years, our industry has taken advantage of the global, integrated economy. The vast majority of global ...